Related Experiment Videos
Identification of a novel mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency
1Kimberly H. Courtwright & Joseph W. Summers Institute of Metabolic Disease, Baylor University Medical Center, Dallas, Texas 75226, USA.
Insights
A novel mutation, G617T, was found in medium-chain acyl-CoA dehydrogenase deficiency patients. This genetic finding sheds light on unusual disease presentations and potential therapeutic targets.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is an inherited metabolic disorder affecting fatty acid oxidation.
- Genetic mutations in the ACADM gene are the primary cause of MCAD deficiency.
- Typical presentations include hypoglycemia and lethargy during infancy and early childhood.
Observation:
- Two unrelated patients presented with atypical clinical manifestations of MCAD deficiency.
- One patient, a 19-year-old female, experienced a severe, fatal illness in adulthood, an unusual outcome for MCAD deficiency.
- The second patient, a male, presented at 17 months with hypoglycemic seizure and dehydration.
Findings:
- Sequence analysis identified a novel mutation, G617T in exon 8 of the ACADM gene, leading to an arginine to leucine substitution at codon 206 (R206L).
- Both patients were found to be compound heterozygous, carrying this novel G617T mutation along with the common A985G mutation.
- The novel R206L substitution is implicated in the observed severe and atypical clinical phenotypes.
Implications:
- This discovery expands the spectrum of known ACADM mutations and their associated clinical presentations.
- Understanding this novel mutation may improve diagnostic strategies for medium-chain acyl-CoA dehydrogenase deficiency.
- Further research into the functional impact of the R206L mutation could inform therapeutic interventions for MCAD deficiency.
Abstract:
A novel mutation was identified in two unrelated patients with medium-chain acyl-CoA dehydrogenase deficiency. First, a 19-year-old Caucasian female presented with a devastating illness, resulting in sudden death in adulthood which is unusual. The second patient, now a 3.5-year-old male, presented at 17 months of age with a hypoglycemic seizure and dehydration. Sequence analysis revealed a novel mutation G617T in exon 8 resulting in an arginine to leucine substitution at codon 206 (R206L). Both patients were compound heterozygous for this G617T and the common mutation A985G.